Located within BioLabs for Advanced Therapeutics Philadelphia, a newly expanded 53,000-square-foot biotech incubator, the Philadelphia ATxCC aims to provide emerging startups and biopharma organizations with direct access to Thermo Fisher’s scientists, advanced process development technologies, and collaboration opportunities. Learn more here.